CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$2.59. The highest annual figure on record is -$2.02 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.59 | – |
| FY2024 | Dec 31, 2024 | -$2.56 | – |
| FY2023 | Dec 31, 2023 | -$2.02 | – |
| FY2022 | Dec 31, 2022 | -$3.01 | – |
| FY2021 | Dec 31, 2021 | -$2.69 | – |
| FY2020 | Dec 31, 2020 | -$4.37 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?